Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02535078 |
|---|---|
| Brief Title: | Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma |
| First Submitted : | August 26, 2015 |
| First Submitted that Met QC Criteria : | August 27, 2015 |
| First Posted : | August 28, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 9, 2021 |
| Last Update Posted : | April 14, 2021 (Estimate) |